midostaurin
novartis
['midostaurin']
i calculated 6.3% of 540 patients (35-40) only enrolled in usa. study opened in sep 2016 so for 8 months before approval of midostaurin in usa end of april 2017 suggesting little accrual from usa after soc in usa changed. doctors always want to do good by their patients #eha2022 
Director-Heme Early Therapeutics & Leader-Leukemia/Myeloid Research @Yale. Personal views. I tweet on cancer, travel, food & soccer. COI: https://t.co/6XkF8CmtrK